PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
Cyclohexanecarbonitrile 212-157-4 766-05-2 - - - - 1 - - - - Details
Cyclohexanol 203-630-6 108-93-0 - - 2 - - - - - - Details
Cyclohexanone 203-631-1 108-94-1 1 - 2 - 1 - - - - Details
Cyclohexanone, peroxide 235-527-7 12262-58-7 - - 1 - - - - - - Details
Cyclohexenecarbonitrile 217-454-2 1855-63-6 - - - - 1 - - - - Details
Cyclohexyl 2-hydroxybenzoate 607-733-0 25485-88-5 - - - - 1 - - - - Details
Cyclohexyl isocyanate 221-639-3 3173-53-3 - - - - 1 - - - - Details
Cyclohexyl methacrylate 202-943-5 101-43-9 - - 3 - 1 - - - - Details
cyclohexyl salicylate 400-410-3 25485-88-5 - - 1 - 1 - - - - Details
Cyclohexylamine 203-629-0 108-91-8 1 - 1 - - - - - - Details
Cyclohexylbenzene 212-572-0 827-52-1 - - - - 1 - - - - Details
Cyclohexyldimethoxymethylsilane
CHMMS; CHMS; DYNASYLAN 9407; Z-6187
402-140-1 17865-32-6 - - 1 - - - - - - Details
Cyclohexyldimethylamine 202-715-5 98-94-2 - - 2 - - - - - - Details
Cyclohexylhydroxydiazene 1-oxide, potassium salt (This entry also covers the hydrated forms of K-HDO) 613-953-8 66603-10-9 - - - 1 - 1 - - - Details
Cyclohexylidenebis[tert-butyl] peroxide 221-111-2 3006-86-8 - - 2 - - - - - - Details
Cyclooctanone 207-940-2 502-49-8 - - - - 1 - - - - Details
Cyclopentadec-4-en-1-one 252-692-0 35720-57-1 - - - - 1 - - - - Details
Cyclopentadec-4-yn-1-one 604-281-6 14224-80-7 - - - - 1 - - - - Details
Cyclopentadecanone 207-951-2 502-72-7 - - 1 - 1 - - - - Details
Cyclopentanone 204-435-9 120-92-3 - - 1 - 1 - - - - Details
cyclopentyl 2-phenylethyl ether 428-340-9 238088-70-5 - - - - 1 - - - - Details
Cyclopentyl methyl ether 611-360-9 5614-37-9 - - - - 1 - - - - Details
cyclopentyl methyl ether 445-090-6 5614-37-9 - - - - 1 - - - - Details
Cyclopentylidenecyclopentan-2-one 212-542-7 825-25-2 - - - - 1 - - - - Details
Cycloxydim 405-230-9 101205-02-1 - - - - - 1 - - - Details
cyflumetofen (ISO); 2-methoxyethyl (RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate 642-974-5 400882-07-7 - - - - - 1 - - - Details
cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 261-043-0 57966-95-7 - - - - - 2 - - - Details
cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol 619-020-1 94361-06-5 - - - - - 1 - - - Details
Cysteine hydrochloride 200-157-7 52-89-1 - - 3 - - - - - - Details
D-Glucitol, 1-deoxy-1-(dimethylamino)- 810-394-3 76326-99-3 - - - - 1 - - - - Details
D-gluconic acid 208-401-4 526-95-4 - - 1 - - - - - - Details
D-gluconic acid, compound with N,N''-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1) 242-354-0 18472-51-0 - - 1 - 1 - - - - Details
D-glucono-1,5-lactone 202-016-5 90-80-2 - - 1 - - - - - - Details
D-Glucopyranose, oligomeric, C10-16(even numbered) alkyl glycosides 600-975-8 110615-47-9 - - 1 - - - - - - Details
D-Glucopyranose, oligomeric, C10-16-alkyl glycosides, 2-hydroxy-3-sulfopropyl ethers, sodium salts 664-492-4 742087-49-6 - - 2 - - - - - - Details
D-Glucopyranose, oligomers, decyl octyl glycosides 500-220-1 68515-73-1 - - 1 - - - - - - Details
D-glucopyranose, oligomers, xylityl glycosides and 1,4 anhydro D-xylitol and D-xylitol 446-990-1 - - - 1 - - - - - - Details
D-Glucose, ether with glycerol 309-496-6 100402-60-6 - - 1 - - - - - - Details
D-p-mentha-1(6),8-dien-2-one 202-759-5 99-49-0 - - - - 1 - - - - Details
D-α-methylbenzylamine 223-423-4 3886-69-9 - - - - 1 - - - - Details
D0787 443-310-5 - - - - - 1 - - - - Details
Daminozide 216-485-9 1596-84-5 - - - - - 1 - - - Details
Dapsone 201-248-4 80-08-0 1 - 2 1 - - - - - Details
Dazomet 208-576-7 533-74-4 - - - - - 1 - - - Details
Dec-1-ene 212-819-2 872-05-9 - - 3 - - - - - - Details
Dec-1-ene, dimers, hydrogenated 500-228-5 68649-11-6 - - 4 - - - - - - Details
Dec-1-ene, homopolymer, hydrogenated Dec-1-ene, oligomers, hydrogenated 500-183-1 68037-01-4 - - 2 - - - - - - Details
Dec-1-ene, trimers, hydrogenated 500-393-3 157707-86-3 - - 4 - - - - - - Details
decachlorotetrasilane 921-774-4 13763-19-4 - - - - 1 - - - - Details
decahydro-2,2,6,6,7,8,8-heptamethyl-2H-Indeno[4,5-b] furan 449-360-4 476332-65-7 - - - - 1 - - - - Details

Export search results to: